Cart
sales@molnova.com
TGFβ-IN-5
CAS No. 259870-32-1
TGFβ-IN-5( —— )
Catalog No. M37121 CAS No. 259870-32-1
TGFβ-IN-5 (WAY-641966) is a potent TGFβ inhibitor with anti-prion activity for the study of fibroproliferative diseases associated with TGF-β signaling.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 82 | In Stock |
|
| 10MG | 124 | In Stock |
|
| 25MG | 212 | In Stock |
|
| 50MG | 300 | In Stock |
|
| 100MG | 431 | In Stock |
|
| 200MG | 603 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTGFβ-IN-5
-
NoteResearch use only, not for human use.
-
Brief DescriptionTGFβ-IN-5 (WAY-641966) is a potent TGFβ inhibitor with anti-prion activity for the study of fibroproliferative diseases associated with TGF-β signaling.
-
DescriptionTGFβ-IN-5(Compd 12) is a TGFβ inhibitor useful for the study of fibroproliferative diseases associated with TGF-β signaling.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorTGF-beta/Smad
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number259870-32-1
-
Formula Weight312.37
-
Molecular FormulaC20H16N4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN=1C=CC(=CC1)CNC=2N=C(N=C3C=CC=CC32)C=4C=CC=CC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. TREATMENT OF FIBROPROLIFERATIVE DISORDERS USING TGF-β INHIBITORS. WO2003097615.
molnova catalog
related products
-
Zucapsaicin
Zucapsaicin (Civanex) is a medication used to treat osteoarthritis of the knee and Others neuropathic pain.Zucapsaicin is a synthetic cis isomer of natural capsaicin that has shown therapeutic efficacy in pain accompanying osteoarthritis of the knee.
-
Genistein 7,4-di-O-b...
Genistein 7,4'-di-O-beta-D-glucopyranoside shows significant estrogenic proliferative effect in MCF-7 cell in sub-cytotoxic concentration range.
-
PD-1/PD-L1-IN 3 TFA
PD-1/PD-L1-IN 3 TFA inhibits the binding of human PD-1 to PD-Ll with an IC50 of 9 nM.
